Placental transfer of intravenous nicardipine and disposition into breast milk during the control of hypertension in women with pre-eclampsia

Hypertension in Pregnancy

Volumn 33, Issue 1, 2014, Pages 93-101

  Matsumura, Hideyoshi ^a   Takagi, Kenjiro ^a   Seki, Hiroyuki ^a   Ono, Yoshihisa ^a   Ichinose, Shunichiro ^a   Masuko, Hiroko ^a   Fukatsu, Mayumi ^a   Miyashita, Aiji ^b   Mera, Ayako ^b  

^a SAITAMA MEDICAL UNIVERSITY   (Japan)

^b ASTELLAS PHARMA INC   (Japan)

Author keywords

Breast milk; Fetus; Neonate; Nicardipine; Placental transfer

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; LACTATE DEHYDROGENASE; NICARDIPINE; ANTIHYPERTENSIVE AGENT;

ABSENCE OF SIDE EFFECTS; ADULT; ANTIHYPERTENSIVE THERAPY; ARTERIAL BLOOD; ARTICLE; BREAST MILK; CLINICAL ARTICLE; DELIVERY; DISEASE SEVERITY; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG DISPOSITION; DRUG MILK LEVEL; DRUG SAFETY; FEMALE; HUMAN; HUMAN TISSUE; MATERNAL HYPERTENSION; MATERNAL PLASMA; NEWBORN; PLACENTAL TRANSFER; PREECLAMPSIA; PREGNANT WOMAN; UMBILICAL CORD BLOOD; VENOUS BLOOD; BLOOD; CHEMISTRY; FETUS BLOOD; METABOLISM; PLACENTA; PRE-ECLAMPSIA; PREGNANCY;

ADULT; ANTIHYPERTENSIVE AGENTS; FEMALE; FETAL BLOOD; HUMANS; INFANT, NEWBORN; MILK, HUMAN; NICARDIPINE; PLACENTA; PRE-ECLAMPSIA; PREGNANCY;

EID: 84891553712     PISSN: 10641955     EISSN: 15256065     Source Type: Journal    
DOI: 10.3109/10641955.2013.846367     Document Type: Article

References (16)

1. Aya AG, Mangin R, Hoffet M, et al. Intravenous nicardipine for severe hypertension in pre-eclampsia-effects of an acute treatment on mother and foetus. Intensive Care Med 1999;25:1277-81.
2. Bartels PA, Hanff LM, Mathot RAA, et al. Nicardipine in pre-eclamptic patients: placental transfer and disposition in breast milk. BJOG 2007;114:230-3. (Pubitemid 46089454)
3. Carbonne B, Jannet D, Touboul C, et al. Nicardipine treatment of hypertension during pregnancy. Obstet Gynecol 1993;81:908-14. (Pubitemid 23168731)
4. Jannet D, Carbonne B, Sebban E, et al. Nicardipine versus metoprolol in the treatment of hypertension during pregnancy: a randomized comparative trial. Obstet Gynecol 1994;84:354-59. (Pubitemid 24267291)
5. Sibai BM. Diagnosis, controversies, and management of the syndrome of hemolysis, elevated liver enzyme and low platelet count. Obstet Gynecol 2004;103:981-91. (Pubitemid 40459001)
6. Itabashi K, Fujimura M, Kusuda S, et al. Introduction of a new birth weight standard according to the gestational age. Report from the Council of Neonate, Japan Pediatric Society. Acta Paediatrica Japonica 2010;114:1271-93. (in Japanese).
7. Ostrea Jr. EM, Mantaring JB III, Silvestre MA. Drugs that affect the fetus and newborn infant via the placenta or breast milk. Pediatr Clin North Am 2004;51: 539-79. (Pubitemid 38638548)
8. Lindheimer MD, Taler SJ, Cunningham FG. American Society of Hypertension. ASH position paper: hypertension in pregnancy. J Clin Hypertens 2009;11:214-25.
9. Lowe SA, Brown MA, Dekker GA, et al. Society of Obstetric Medicine of Australia and New Zealand. Guidelines for the management of hypertensive disorders of pregnancy. Aust N Z J Obstet Gynecol 2009;49:242-6.
10. Hypertension in pregnancy: The management of hypertensive disorders during pregnancy. NICE Clinical Guidelines, No. 107. London: RCOG Press, 2010.
11. Magee LA, Helewa M, Moutquin JM, et al. Hypertension guideline committee; strategic training initiative in research in the reproductive health sciences (STIRRHS) scholars. Diagnosis, evaluation, and management of the hypertensive disorders of pregnancy. J Obstet Gynaecol Can 2008;30:S1-48.
12. Syme MR, Paxton JW, Keelan JA. Drug transfer and metabolism by the human placenta. Clin Pharmacokinet 2004;43:487-514. (Pubitemid 38858303)
13. Anderson GD, Carr DB. Effect of pregnancy on the pharmacokinetics of antihypertensive drugs. Clin Pharmacokinet 2009;48:159-68.
14. Hebert MF, Easterling TR, Kirby B, et al. Effects of pregnancy on CYP3A and P-glycoprotein activities as measured by disposition of midazolam and digoxin: a university of Washington specialized center of research study. Clin Pham Ther 2008;84:248-53.
15. Modi N, Veng-Pedersen P, Graham DJ. Application of a system analysis approach to population pharmacokinetics and pharmacodynamics of nicardipine hydrochloride in healthy males. J Pharm Sci 1993;82:705-13. (Pubitemid 23315689)
16. Higuchi S, Shiobara Y. Comparative pharmacokinetics of nicardipine hydrochloride, a new vasodilator, in various species. Xenobiotica 1980;10:447-54. (Pubitemid 10049541)